42P Comparing survival outcomes in KRAS G12 vs KRAS G13-mutated metastatic colorectal cancer (mCRC): A 13-year cohort studyRosa M. Quinta‐Ferreira, João Gramaça, Nádia Duarte et al.|ESMO Open|2025Cited by 0